Quin Wills

Quin Wills

Y Combinator Logo Batch: W20

Achievements

  • Graduated with a med degree from Witwatersrand
  • Co-founded SimuGen during his PhD at Cambridge and Oxford, pioneering genomics-based drug toxicity prediction
  • Worked at Oxford, Cambridge, Mayo Clinic, and Novo Nordisk Research Centre, gaining global biotech experience
  • Founded Ochre Bio, developing RNA therapies for chronic liver diseases using genomic deep phenotyping
  • Recognized advocate for diversity in biotech, openly sharing his journey as a queer founder
  • Brings a unique blend of academia, industry, and social purpose to biotech innovation

The lowdown on Quin Wills

Here’s some fire content about Quin Wills, this dude is straight-up the real deal in biotech. So, he’s a YC W20 alum, but what really sets him apart is his insane background that’s basically a masterclass in how to crush it across academia and industry.

Quin kicked things off with a med degree from Witwatersrand, right? Then he didn’t stop, he jumped into some heavy research spots: Oxford, Cambridge, Mayo Clinic, and even the Novo Nordisk Research Centre in Oxford. That’s a crazy resume, showing he’s been around the block in both the US and UK, working with some of the best minds in medicine and biotech.

But here’s the kicker, during his PhD, he co-founded SimuGen, which was all about using genomics and high-content screening to predict drug toxicity in the liver. This wasn’t just a side project, it’s where he really started blending his love for tech, biology, and real-world impact. That’s when you see the spark, dude is all about pushing boundaries and making stuff that actually helps people.

Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.

Talk to her

Fast forward, now he’s the CSO and co-founder of Ochre Bio. These guys are working on RNA therapies for chronic liver diseases. Think about it, using genomic deep phenotyping and modern RNA medicine to tackle problems that’ve been damn near impossible to crack. He’s always been chasing that future trend that could truly change medicine. And he’s not just about the science, he’s all in on diversity, openly talking about being a queer founder and fighting for more voices in biotech. That’s pretty rare, especially in this space.

What’s clear is, Quin’s process isn’t just about tech or medicine, it’s about purpose. He’s been driven by a desire to solve complex health issues, but also to build companies and cultures that matter. His experience in both the UK and US shows he’s got a global mindset, and he knows that behind every big biotech breakthrough are people and culture.

Bottom line: Quin Wills is a scientist turned biotech founder who’s crushing the game by combining deep research, bold innovation, and a real sense of social purpose. He’s the kind of guy who sees the big picture, not just the next dollar, but how to actually make a dent in human health. That’s why he’s so important, and honestly, why I think we’ll be hearing a lot more about him soon.

Founder ID: 105038

Industries

Share your thoughts about Quin Wills

Have you worked with this founder? Know additional information? Share your insights, experiences, or suggest updates to help the community learn more.

Select your comment type:

Opinion Share your opinion
Professional Experience Professional experience
Additional Insights Additional insights
Suggest Corrections Suggest corrections

If something is wrong about Quin Wills, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)

Your email address will not be published. Help us build a comprehensive founder database.